SCHEMBL14101567

SCHEMBL14101567

CC1(C)c2cc(-c3ccc4sc5ccc(-c6ccc7ccccc7c6)cc5c4c3)ccc2-c2ccc(-c3ccc4ccc5cccc6ccc3c4c56)cc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 9/20 0.35
S1PR4 O95977 6/20 0.35
GSTP1 P09211 1/20 0.33
LPL P06858 1/20 0.32
LIPG Q9Y5X9 1/20 0.32
ERBB2 P04626 1/20 0.32
CYP1A2 P05177 1/20 0.32
FYN P06241 1/20 0.32
MAOA P21397 1/20 0.32
ACHE P22303 1/20 0.32
AHR P35869 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101506 0.94 ERBB2 (0.31) S1PR5S1PR4ERBB2CYP1A2FYN
SCHEMBL14101563 0.93 CYP1A2 (0.35) S1PR5S1PR4ERBB2CYP1A2FYN
SCHEMBL14101679 0.93 ERBB2 (0.32) S1PR5S1PR4ERBB2CYP1A2FYN
SCHEMBL14101499 0.92 ERBB2 (0.33) S1PR5S1PR4ERBB2CYP1A2FYN
SCHEMBL14101529 0.89 S1PR5 (0.41) S1PR5S1PR4GSTP1ERBB2CYP1A2
SCHEMBL14101504 0.89 CYP1A2 (0.33) ERBB2CYP1A2FYNMAOAACHE
SCHEMBL14101498 0.88 PDK2 (0.33)
SCHEMBL14101441 0.88 S1PR5 (0.42) S1PR5S1PR4GSTP1ERBB2CYP1A2
SCHEMBL14101463 0.87 S1PR5 (0.40) S1PR5S1PR4GSTP1ERBB2CYP1A2
SCHEMBL14101456 0.87 S1PR5 (0.40) S1PR5S1PR4GSTP1ERBB2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR S1PR5 4736/4885S1PR4 4464/4885GSTP1 731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.